India's Diagnostic Gap: Quality Concerns Emerge

Accurate medical diagnosis is the cornerstone of effective treatment, yet diagnostic errors contribute significantly to the global disease burden. In India, an estimated 70% of clinical decisions rely on diagnostic tests, making quality a critical patient safety imperative. Inaccurate reports can lead to misdiagnosis, delayed treatment, and financial hardship.

Quality in diagnostics encompasses the entire process, from sample collection to result reporting. While technology is an enabler, qualified professionals and robust quality management systems are essential. India faces challenges with uneven quality standards, with only around 2,500 of its estimated 300,000 diagnostic laboratories being NABL-accredited.

This disparity creates a significant quality gap between established and smaller facilities. Addressing this requires a nationally recognised accreditation framework with consistent regulatory oversight. Simplified accreditation processes and financial incentives are crucial for smaller laboratories to meet quality benchmarks.

The pre-analytical phase, including patient preparation and sample handling, is particularly vulnerable. Standardised protocols and continuous training are vital as diagnostic services expand. Unrealistic price caps on tests can also compromise quality, leading to potential errors and increased costs for patients.

Investing in qualified personnel, modern equipment, and quality assurance is paramount. Embedding quality, patient safety, and accurate diagnostics into medical education will foster a culture of reliability. India has the potential to be a global hub for quality diagnostics with consistent standards across all types of facilities.